Special journal issue on pediatric genomic medicine

Clinical Therapeutics (CT) is seeking papers for a specialty topic update on value, implementation, and access to pediatric genomic medicine. This themed section will be co-edited by Tara Lavelle and Hadley Stevens Smith. Additional information about topics of interest and the journal can be found here.

If you are interested in contributing, please send Tara and Hadley an email by July 31 that includes the title, article type (original article, review, or commentary), and abstract (< 400 words) of your proposed manuscript. They will be in touch after abstracts are evaluated to communicate the deadline for the full manuscript. All invited papers will undergo rigorous peer review and will not be subject to submission fees or page charges.

Please share this Call for Papers with colleagues and students who are working on issues of value, implementation, and access to pediatric genomic medicine, as Tara and Hadley hope to recruit a diverse array of experts for this special edition.

Contact details for Tara and Hadley are as follows:

  • Tara Lavelle, PhD (tlavelle@tuftsmedicalcenter.org) | Assistant Professor, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
  • Hadley Stevens Smith, PhD, MPSA (hadley.smith@bcm.edu) | Postdoctoral Research Fellow in Health Policy, Center for Medical Ethics and Health Policy, Baylor College of Medicine | Incoming faculty, Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute

New Journal Special Issue Announced

The Journal of Community Genetics has just announced a new Special Issue titled “Resource Allocation in Genomic Medicine”. I will be guest editing this Special Issue with Dr Ilias Goranitis (University of Melbourne) and Ingrid Slade (University of Oxford; Head of Public Health, Wokingham Borough Council).

The Special Issue will focus on the issues surrounding resource allocation in genomic medicine from a variety of perspectives. Articles should aim to explore and describe best practice in resource allocation in this context and highlight key challenges, particularly those that are generalizable internationally.

Contributions are invited on, but not restricted to, the following themes:

  • Valuing genomic tests – challenges in the health technology assessment process;
  • Ethical, legal and social issues associated with resource allocation in genomic medicine;
  • The role of patients in resource allocation decision making in genomic medicine;
  • Commissioning genomic services within health systems;
  • Policy issues surrounding the translation of genomic medicine into clinical practice;
  • Resource allocation issues related to genomic testing in primary care and the wider community;
  • Resource allocation issues related to implementing genomic medicine in low- and middle-income countries;
  • Incorporating the wider economic impacts of genome sequencing in resource allocation decisions.

The deadline for submissions is 1st March 2021, and the Special Issue will be published in summer 2021.

Full details available here. Any questions, don’t hestiate to drop either me or Ilias an email.